Anemia aplastik Dokter Terbaik di Israel - TOP-18 dokter

Informasi dokter sedang diperbarui. Dr. Ron berpraktik di Sourasky Medical Center (Ichilov).

Dr. Ram telah melakukan beberapa ratus transplantasi sel punca – pengobatan utama untuk anemia aplastik – di Sourasky Medical Center.

• Tersertifikasi dewan dalam Hematologi dan Onkologi Medis
• Menjalani pelatihan Fellowship di Westchester Medical Center di New York
• Menulis lebih dari 30 artikel ilmiah dan satu bab buku teks
• Pengalaman luas dalam gangguan sumsum tulang yang kompleks

300+ transplantasi sumsum tulang dan darah tali pusat – Dr. El Hasid memimpin onkohematologi pediatrik di Rumah Sakit Anak Dana Dwek.

• Kepala Departemen Onkohematologi dan Onkologi Pediatrik
• Anggota Asosiasi Hematologi Amerika
• Menerbitkan 50 makalah penelitian di bidang tersebut
• Pelatihan di Rumah Sakit City of Hope di Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

900+ transplantasi sumsum tulang telah dilakukan – Dr. Michael Shapira adalah ahli hematologi terkemuka di Sourasky Medical Center.

• Mengambil spesialisasi dalam transplantasi sumsum tulang di Hadassah Medical Center
• Diakui karena memajukan kedokteran transplantasi
• Berbicara bahasa Inggris dan Ibrani dengan lancar
• Lulus dari sekolah kedokteran Hebrew University

Kepala Institut Hematologi dan Transplantasi Sumsum Tulang di Sourasky Medical Center – Dr. Aviv menghadirkan kepemimpinan dan keahlian mendalam dalam anemia aplastik.

• 31 tahun spesialisasi dalam hematologi dan onkologi
• Bersertifikat dewan dengan berbagai keanggotaan masyarakat profesional
• Berfokus pada sindrom mielodisplastik dan transplantasi

Direktur hematologi onkologi anak di Sourasky Medical Center – Dr. Levin mendalami spesialisasi dalam kelainan darah dan kanker tulang pada anak.

• Mengoordinasikan pengobatan sarkoma dengan departemen Onkologi-ortopedi
• Ahli hematologi untuk bayi prematur
• Dilatih di Institut Ortopedi Rizzoli di Italia
• Anggota ISPHO – Asosiasi hemato-onkologi pediatrik Israel

Dr. Kirshner terlibat dalam penelitian mutakhir dan uji klinis untuk anemia aplastik, termasuk uji klinis fase III di Sourasky Medical Center.

• Menyelesaikan pelatihan fellowship hematologi di Montefiore Medical Center
• Spesialisasi dalam kelainan darah langka seperti anemia aplastik
• Pengalaman lebih dari 30 tahun di bidang hematologi dan onkologi
• Fokus penelitian pada protokol pengobatan inovatif
• Fellow dari American Society of Hematology

Dr. Herishanu Yair telah menerima berbagai penghargaan atas kontribusinya di bidang hematologi, termasuk Young Investigator Research Prize dan Klitzberg Oncology Award.

• Berspesialisasi dalam leukemia limfositik kronis dan anemia aplastik
• Anggota dari Asosiasi Hematologi Israel dan Amerika
• Menerbitkan penelitian luas di bidang hematologi
• Menempuh pendidikan di institusi medis terkemuka di Israel

Telah melakukan lebih dari 3.500 transplantasi sumsum tulang – diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018.

• 20 tahun pengalaman dalam hematologi anak
• Spesialisasi dalam mengobati anak-anak dengan kelainan darah langka
• Dikenal di kalangan pasien sebagai 'sosok yang mentransplantasikan kehidupan'
• Bekerja di Hadassah Medical Center

Dr. Irina Zaidman spesialis dalam transplantasi sumsum tulang pediatrik – sebuah perawatan kritis untuk anemia aplastik – di Hadassah Medical Center.

• Fellowship dalam transplantasi sumsum tulang pediatrik di Hospital for Sick Children di Toronto
• Anggota dewan dari Masyarakat Hemato-Onkologi Pediatrik Israel
• Anggota dari masyarakat transplantasi sumsum tulang Eropa dan Amerika
• Penelitian yang dipublikasikan tentang transplantasi sumsum tulang pediatrik

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Spielberg adalah seorang onkohematolog berdedikasi di Pusat Medis Assuta, yang berspesialisasi dalam gangguan darah seperti anemia aplastik.

• Berfokus pada diagnosis dan perencanaan perawatan yang komprehensif
• Menjadi ahli dalam menangani sindrom kegagalan sumsum tulang
• Bekerja di rumah sakit swasta terbesar di Israel, Pusat Medis Assuta
• Memberikan perawatan yang dipersonalisasi untuk kondisi hematologi yang kompleks

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.